Jonathan Freve
First SEC filing: Oct. 28, 2020 · Latest: Oct. 28, 2020
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Jan. 3, 2024 | DMRA | A | 100,000 | · | · | 100,000 Direct | · | Acquired | (price as of 2026-10-02) |
| Jan. 4, 2023 | DMRA | A | 115,000 | · | · | 115,000 Direct | · | Acquired | (price as of 2026-10-02) |
| Jan. 4, 2022 | DMRA | A | 118,750 | · | · | 118,750 Direct | · | Acquired | (price as of 2026-10-02) |
| Dec. 3, 2021 | DMRA | P | 4,000 | $2.49 | $9,960 | 12,000 Direct | +50.00% | Acquired | -66.8% (price as of 2026-10-02) |
| Nov. 8, 2021 | DMRA | P | 3,000 | $3.40 | $10,200 | 8,000 Direct | +60.00% | Acquired | -75.7% (price as of 2026-10-02) |
| Aug. 18, 2021 | DMRA | P | 3,000 | $3.92 | $11,760 | 5,000 Direct | +150.00% | Acquired | -78.9% (price as of 2026-10-02) |
| June 23, 2021 | DMRA | P | 2,000 | $4.74 | $9,480 | 2,000 Direct | · | Acquired | -82.6% (price as of 2026-10-02) |
| Jan. 5, 2021 | DMRA | A | 95,000 | · | · | 95,000 Direct | · | Acquired | (price as of 2026-10-02) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Jan. 3, 2024 | DMRA | Restricted Stock Units | Common Stock | $0.00 | · | 100,000 | Acquired |
| Jan. 4, 2023 | DMRA | Stock Option (right to buy) | Common Stock | $1.21 | Jan. 3, 2033 | 115,000 | Acquired |
| Jan. 4, 2022 | DMRA | Stock Option (right to buy) | Common Stock | $3.24 | Jan. 3, 2032 | 118,750 | Acquired |
| Jan. 5, 2021 | DMRA | Stock Option (right to buy) | Common Stock | $13.00 | Jan. 5, 2031 | 95,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 1 holding
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| Oct. 28, 2020 | DMRA | Stock Option (right to buy) | 217,074 | Direct |
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2024 | $328,182 | · | $71,000 | · | · | · | $420,572 | $819,754 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.